S&P 500   3,256.22 (-1.63%)
DOW   26,331.43 (-1.23%)
QQQ   268.18 (-2.97%)
AAPL   109.19 (-5.32%)
MSFT   200.00 (-2.31%)
FB   262.16 (-6.65%)
GOOGL   1,613.25 (+3.62%)
AMZN   3,055.57 (-4.84%)
TSLA   386.00 (-6.04%)
NVDA   496.27 (-4.74%)
BABA   300.90 (-3.73%)
CGC   18.24 (-2.88%)
GE   7.32 (-0.68%)
MU   49.57 (-1.80%)
AMD   74.74 (-4.20%)
T   26.76 (+0.00%)
F   7.67 (-2.91%)
ACB   3.92 (-4.16%)
GILD   57.22 (-2.24%)
NIO   30.34 (-5.16%)
NFLX   476.87 (-5.42%)
BA   142.50 (-3.90%)
DIS   119.20 (-1.93%)
S&P 500   3,256.22 (-1.63%)
DOW   26,331.43 (-1.23%)
QQQ   268.18 (-2.97%)
AAPL   109.19 (-5.32%)
MSFT   200.00 (-2.31%)
FB   262.16 (-6.65%)
GOOGL   1,613.25 (+3.62%)
AMZN   3,055.57 (-4.84%)
TSLA   386.00 (-6.04%)
NVDA   496.27 (-4.74%)
BABA   300.90 (-3.73%)
CGC   18.24 (-2.88%)
GE   7.32 (-0.68%)
MU   49.57 (-1.80%)
AMD   74.74 (-4.20%)
T   26.76 (+0.00%)
F   7.67 (-2.91%)
ACB   3.92 (-4.16%)
GILD   57.22 (-2.24%)
NIO   30.34 (-5.16%)
NFLX   476.87 (-5.42%)
BA   142.50 (-3.90%)
DIS   119.20 (-1.93%)
S&P 500   3,256.22 (-1.63%)
DOW   26,331.43 (-1.23%)
QQQ   268.18 (-2.97%)
AAPL   109.19 (-5.32%)
MSFT   200.00 (-2.31%)
FB   262.16 (-6.65%)
GOOGL   1,613.25 (+3.62%)
AMZN   3,055.57 (-4.84%)
TSLA   386.00 (-6.04%)
NVDA   496.27 (-4.74%)
BABA   300.90 (-3.73%)
CGC   18.24 (-2.88%)
GE   7.32 (-0.68%)
MU   49.57 (-1.80%)
AMD   74.74 (-4.20%)
T   26.76 (+0.00%)
F   7.67 (-2.91%)
ACB   3.92 (-4.16%)
GILD   57.22 (-2.24%)
NIO   30.34 (-5.16%)
NFLX   476.87 (-5.42%)
BA   142.50 (-3.90%)
DIS   119.20 (-1.93%)
S&P 500   3,256.22 (-1.63%)
DOW   26,331.43 (-1.23%)
QQQ   268.18 (-2.97%)
AAPL   109.19 (-5.32%)
MSFT   200.00 (-2.31%)
FB   262.16 (-6.65%)
GOOGL   1,613.25 (+3.62%)
AMZN   3,055.57 (-4.84%)
TSLA   386.00 (-6.04%)
NVDA   496.27 (-4.74%)
BABA   300.90 (-3.73%)
CGC   18.24 (-2.88%)
GE   7.32 (-0.68%)
MU   49.57 (-1.80%)
AMD   74.74 (-4.20%)
T   26.76 (+0.00%)
F   7.67 (-2.91%)
ACB   3.92 (-4.16%)
GILD   57.22 (-2.24%)
NIO   30.34 (-5.16%)
NFLX   476.87 (-5.42%)
BA   142.50 (-3.90%)
DIS   119.20 (-1.93%)
Log in
NASDAQ:ACHV

Achieve Life Sciences Stock Forecast, Price & News

$7.80
-0.37 (-4.53 %)
(As of 10/30/2020 11:29 AM ET)
Add
Compare
Today's Range
$7.80
Now: $7.80▼
$8.03
50-Day Range
$7.31
MA: $8.96▼
$10.97
52-Week Range
$4.51
Now: $7.80▼
$28.00
Volume101 shs
Average Volume227,937 shs
Market Capitalization$27.98 million
P/E RatioN/A
Dividend YieldN/A
Beta1.75
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Read More
Achieve Life Sciences logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.49 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Diagnostic substances
Sub-IndustryBiotechnology
SectorMedical
Current SymbolNASDAQ:ACHV
Previous Symbol
CUSIP68230A10
CIK949858
Webachievelifesciences.com
Phone604-210-2217
Employees14

Debt

Debt-to-Equity Ratio0.01
Current Ratio6.99
Quick Ratio6.99

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book Value$12.24 per share
Price / Book0.64

Profitability

EPS (Most Recent Fiscal Year)($39.80)
Net Income$-16,400,000.00
Net MarginsN/A
Return on Equity-94.12%
Return on Assets-79.84%

Miscellaneous

Outstanding Shares3,587,000
Market Cap$27.98 million
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
$7.80
-0.37 (-4.53 %)
(As of 10/30/2020 11:29 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ACHV News and Ratings via Email

Sign-up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Achieve Life Sciences (NASDAQ:ACHV) Frequently Asked Questions

How has Achieve Life Sciences' stock been impacted by COVID-19 (Coronavirus)?

Achieve Life Sciences' stock was trading at $8.3240 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ACHV stock has decreased by 6.3% and is now trading at $7.80.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Achieve Life Sciences?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Achieve Life Sciences.

When is Achieve Life Sciences' next earnings date?

Achieve Life Sciences is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Achieve Life Sciences.

How were Achieve Life Sciences' earnings last quarter?

Achieve Life Sciences, Inc. (NASDAQ:ACHV) issued its earnings results on Thursday, August, 6th. The biopharmaceutical company reported ($1.68) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($3.80) by $2.12.
View Achieve Life Sciences' earnings history.

When did Achieve Life Sciences' stock split? How did Achieve Life Sciences' stock split work?

Achieve Life Sciences's stock reverse split on Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 30th 2020. An investor that had 100 shares of Achieve Life Sciences stock prior to the reverse split would have 5 shares after the split.

What price target have analysts set for ACHV?

4 brokers have issued twelve-month price objectives for Achieve Life Sciences' shares. Their forecasts range from $21.00 to $100.00. On average, they anticipate Achieve Life Sciences' stock price to reach $47.75 in the next twelve months. This suggests a possible upside of 512.2% from the stock's current price.
View analysts' price targets for Achieve Life Sciences.

Who are some of Achieve Life Sciences' key competitors?

Some companies that are related to Achieve Life Sciences include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Immunomedics (IMMU), Incyte (INCY), Exact Sciences (EXAS), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Neurocrine Biosciences (NBIX), Repligen (RGEN) and Ionis Pharmaceuticals (IONS).
View all competitors.

What other stocks do shareholders of Achieve Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), BioNano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), Cannabics Pharmaceuticals (CNBX), KushCo (KSHB) and Pennsylvania Real Estate Investment Trust (PEI).

Who are Achieve Life Sciences' key executives?

Achieve Life Sciences' management team includes the following people:
  • Dr. Richard A. B. Stewart, Exec. Chairman (Age 61, Pay $687.5k)
  • Mr. John A. Bencich, CEO & Director (Age 43, Pay $526.89k)
  • Dr. Cindy Jacobs, Pres & Chief Medical Officer (Age 62, Pay $537.2k)
  • Dr. Anthony Clark, Chief Scientific Officer (Age 64, Pay $546k)
  • Mr. Jerry Wan, Principal Accounting Officer

What is Achieve Life Sciences' stock symbol?

Achieve Life Sciences trades on the NASDAQ under the ticker symbol "ACHV."

How do I buy shares of Achieve Life Sciences?

Shares of ACHV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Achieve Life Sciences' stock price today?

One share of ACHV stock can currently be purchased for approximately $7.80.

How big of a company is Achieve Life Sciences?

Achieve Life Sciences has a market capitalization of $27.98 million. The biopharmaceutical company earns $-16,400,000.00 in net income (profit) each year or ($39.80) on an earnings per share basis. Achieve Life Sciences employs 14 workers across the globe.

What is Achieve Life Sciences' official website?

The official website for Achieve Life Sciences is achievelifesciences.com.

How can I contact Achieve Life Sciences?

Achieve Life Sciences' mailing address is 1040 WEST GEORGIA STREET SUITE 1030, VANCOUVER BC, V6E 4H1. The biopharmaceutical company can be reached via phone at 604-210-2217 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.